Vincerx Pharma, Inc. (VINC) has 25 open-market insider trades by 9 insiders since 2021. The most active filer is Ahmed Hamdy M.D., CEO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Andrew I. McDonald | Dir | — | 1 | $495K | 2021-06-29 |
| Ahmed Hamdy M.D. | CEO | — | 5 | $351K | 2023-08-10 |
| Alexander A. Seelenberger | CFO | — | 3 | $235K | 2023-08-11 |
| Christopher P. Lowe | Dir | — | 2 | $176K | 2022-08-25 |
| Raquel E. Izumi | — | — | 4 | $109K | 2023-08-10 |
| Laura I. Bushnell | Dir | — | 3 | $77K | 2022-06-09 |
| Tom C. Thomas | — | — | 4 | $46K | 2023-08-10 |
| Sooin Hwang | Chief Business Officer | — | 2 | $36K | 2021-12-23 |
| John H. Lee | Dir | — | 1 | $10K | 2021-06-29 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Alexander A. Seelenberger | — | Buy | $10K | 2023-08-11 |
| Tom C. Thomas | — | Buy | $5K | 2023-08-10 |
| Ahmed Hamdy M.D. | — | Buy | $21K | 2023-08-09 |
| Raquel E. Izumi | — | Buy | $15K | 2023-08-09 |
| Raquel E. Izumi | — | Buy | $25K | 2022-12-14 |
| Ahmed Hamdy M.D. | CEO | Buy | $31K | 2022-12-14 |
Companies that share insiders with VINC, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Tom C. Thomas | — | Buy | $6K | 2022-12-14 |
| Christopher P. Lowe | Director | Buy | $50K | 2022-08-24 |
| Raquel E. Izumi | — | Buy | $56K | 2022-06-27 |
| Ahmed Hamdy M.D. | CEO | Buy | $34K | 2022-06-23 |
| Laura I. Bushnell | Director | Buy | $29K | 2022-06-09 |
| Sooin Hwang | Chief Business Officer | Buy | $30K | 2021-12-23 |
| Ahmed Hamdy M.D. | CEO | Buy | $65K | 2021-12-22 |
| Laura I. Bushnell | Director | Buy | $25K | 2021-12-22 |
| Alexander A. Seelenberger | CFO | Buy | $25K | 2021-12-22 |